课题基金 / 基金详情

项目摘要

项目成果

MARIANO ESTEBAN的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The antiviral and antiproliferative actions of interferons have been correlated with a number of enzyme activities (2-5A synthetase, endoribonuclease, protein kinase), which, when activiated, inhibit protein synthesis but the relevance of these enzymes to the inhibition of replication of RNA and DNA-containing viruses has not been elucidated. We have found in a vaccinia virus infected mouse L cell system that the interferon-mediated inhibition of viral protein synthesis in vivo correlates with activation of the 2-5A synthetase/endonuclease and degradation of viral RNAs. In contrast, in a number of mouse and human cells of different origins, vaccinia protein synthesis is not inhibited by interferon and a novel phenomenon has been discovered where vaccinia products block the 2-5A synthetase and protein kinase activities. In this proposal, experiments are described using vaccinia virus as a model system to elucidate: a) the in vivo role of the 2-5A synthetase/endonuclease system in the interferon-mediated inhibition of vaccinia virus protein synthesis; b) the mechanism by which a DNA virus such as vaccinia escapes blockade by the interferon system. To determine the in vivo role of the 2-5A synthetase/endonuclease on protein synthesis we will establish to what extent the integrity of viral and cellular RNAs is related to a block of translation, if specific degradation of certain RNAs occurs and if these events are the result of the formation of viral RNA during the course of infection. To define how vaccinia virus escapes inhibition by the interferon-mediated enzyme activities, we will characterize the nature and mode of action of vaccinia products with interfering properties present in cell-extracts and virions. To further define the vaccinia products with blocking effects on interferon action we will examine whether viral genes introduced into cells by DNA-mediated gene transfer can overcome specific interferon-mediated enzyme activities. By examining these cell-systems where the interferon response of the cells may be controlled by vaccinia gene(s) we may provide the means to define the mechanisms responsible for inhibition of replication of various viruses as well as the antiproliferative actions of interferons.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Gene-transfer, stability, and biochemical properties of animal cells transformed with vaccinia DNA.
用痘苗 DNA 转化的动物细胞的基因转移、稳定性和生化特性。
DOI: 10.1016/0042-6822(82)90236-7
发表时间: 1982
期刊: Virology
影响因子: 3.7
作者: [Pellicer,A, Esteban,M]
通讯作者: Esteban,M
Antiviral effect of prostaglandins of the A series: inhibition of vaccinia virus replication in cultured cells.
A系列前列腺素的抗病毒作用:抑制培养细胞中痘苗病毒的复制。
DOI: 10.1099/0022-1317-63-2-435
发表时间: 1982
期刊: The Journal of general virology
影响因子: --
作者: [Santoro,MG, Jaffe,BM, Garaci,E, Esteban,M]
通讯作者: Esteban,M
Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system.
痘苗病毒对干扰素的耐药性与病毒与干扰素系统之间的干扰现象有关。
DOI: 10.1016/0042-6822(84)90268-x
发表时间: 1984
期刊: Virology
影响因子: 3.7
作者: [Paez,E, Esteban,M]
通讯作者: Esteban,M
Interferon inhibits marker rescue of vaccinia virus.
干扰素抑制痘苗病毒的标记拯救。
DOI: 10.1089/jir.1985.5.247
发表时间: 1985
期刊: Journal of interferon research
影响因子: --
作者: [Paez,E, Esteban,M]
通讯作者: Esteban,M
11
    FUSION PROTEIN AS IMMUNOGENS AGAINST HIV INFECTION
    • 批准号:
      2067224
    • 项目类别:
    • 资助金额:
      $17.81万
    • 财政年份:
      1992
    • 负责人:
      MARIANO ESTEBAN
    • 依托单位:
    FUSION PROTEIN AS IMMUNOGENS AGAINST HIV INFECTION
    • 批准号:
      3147383
    • 项目类别:
    • 资助金额:
      $17.12万
    • 财政年份:
      1992
    • 负责人:
      MARIANO ESTEBAN
    • 依托单位:
    FUSION PROTEIN AS IMMUNOGENS AGAINST HIV INFECTION
    • 批准号:
      3147382
    • 项目类别:
    • 资助金额:
      $16.02万
    • 财政年份:
      1992
    • 负责人:
      MARIANO ESTEBAN
    • 依托单位:
    MECHANISMS OF ACTION OF INTERFERON
    • 批准号:
      3186792
    • 项目类别:
    • 资助金额:
      $13.59万
    • 财政年份:
      1983
    • 负责人:
      MARIANO ESTEBAN
    • 依托单位: